Jeremiah Helm Quoted on Supreme Court’s Skinny Label Patent Infringement Decision in Hikma v. Amarin
Knobbe Martens partner Jeremiah Helm was quoted by Bloomberg Law, Law360, and MLex on the U.S. Supreme Court’s unanimous ruling in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., which...
AI Training and Fair Use
Key Takeaways: While the legal landscape is continuing to take shape, a number of recent court decisions indicate that unlicensed use of copyrighted data to train AI models generally constitutes...
Epineuron Receives 510(k) Clearance for Nerve Stimulator
Epineuron Technologies, a Canada-based clinical-stage nerve care company developing a bioelectronic therapy for the treatment of injured peripheral nerves, announced on May 12 that it has received 510(k) clearance of its Evala® Nerve Stimulator from the...
Energy for the AI Boom: Why the Nextera–Dominion Merger Could Reshape the Race to Power Data Centers
Key Takeaways: NextEra Energy and Dominion Energy recently announced a merger that would combine the biggest renewable energy developer in the country with the utility company powering the largest data...
What Inventors Should Know About AI-Assisted Inventions and Their Patentability
Key Takeaways: AI-assisted inventions are patentable under U.S. law, but only a person can be named as an inventor. The legal standard is the same regardless of whether AI was...
Litigation Update | May 2026
USPTO Director Signals Continued Pro-Patent Discretionary Denial Policy at the Patent Trial and Appeal Board Ted M. Cannon In a precedential decision in Magnolia Medical Technologies, Inc. v. Kurin, Inc.,...
Trademark & Brand Protection Update | May 2026
Taylor Swift, Trademarks, and the Pursuit of a Federal Right of Publicity Dillon A. Koch & Jonathan Menkes Taylor Swift’s recent trademark filings for her voice and likeness point to a...
Aerospace Update | May 2026
Proposal for Streamlined U.S. Regulatory Approval for Novel Commercial Space Activities Tyler S. Cox Office of Space Commerce (“OSC”) has released a proposal for streamlining regulatory approval of novel commercial...
Life Science Update | May 2026
AI Risks With the Patent Office: What Life Science Companies Should Be Asking Now Robert J. Hilton, Ph.D. & Justin Culbertson, Ph.D. AI tools are reshaping patent preparation and prosecution,...
